The report provides insights into GSK's tech activities, including its digital transformation strategies, its innovation programs, and its technology initiatives.Dublin, Feb. 06, 2025 (GLOBE NEWSWIRE) ...
Barclays analyst Emily Field maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of £14.50. The ...
GSK PLC closed 18.56% below its 52-week high of £18.24, which the company reached on May 16th.
GSK launched a 2 billion pounds ($2.5 billion) share buyback on Wednesday and lifted its long-term sales target to nearly $50 billion, betting that growing sales of its HIV and cancer drugs will make ...
Annual core operating profit increased in 2024 for British pharmaceutical company GSK compared to 2023, the company reported ...
UBS analyst Jo Walton maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of £15.80. The company’s ...
European markets opened mixed on Wednesday, with investors looking ahead to more earnings from a number of key companies.
GSK PLC closed 24.32% short of its 52-week high of £18.24, which the company achieved on May 16th.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results